Solid Biosciences LLC
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -467 | -376 | -386 | -407 |
EBITDA | -48,936 | -45,400 | -39,034 | -38,807 |
EBIT | -49,403 | -45,776 | -39,420 | -39,214 |
Net Income | -49,787 | -45,776 | -39,480 | -39,282 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -54,120 | -33,557 | -37,789 | -31,976 |
Cash | 61,122 | 61,364 | 138,933 | 210,629 |
Basic Shares | 94,731 | 94,417 | 94,140 | 66,341 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $8,094 |
Gross Profit | -1,636 | -2,455 | -2,581 | 8,094 |
EBITDA | -177,570 | -121,902 | -93,434 | -96,866 |
EBIT | -179,206 | -124,357 | -96,015 | -99,274 |
Net Income | -174,325 | -124,697 | -96,015 | -85,981 |
Net Change In Cash | 0 | 0 | 0 | 8,094 |
Cost of Revenue | 36,011 | |||
Free Cash Flow | -157,442 | -100,666 | -95,695 | -100,992 |
Cash | 59,900 | 80,235 | 74,015 | 155,384 |
Basic Shares | 87,504 | 40,817 | 19,884 | 8,512 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.53 |
2025-09-30 | -$0.48 |
2025-06-30 | -$0.42 |
2025-03-31 | -$0.59 |
